Could 2022 be the year Kentucky legalizes medical marijuana?
KentuckyMarijuana Industry NewsMedical Marijuana January 5, 2022 MJ Shareholders 0
The Kentucky General Assembly convened for the first day of the 2022 legislative session Tuesday and legalizing medical marijuana in the Commonwealth is one issue that will likely be up for debate.
Senate President Robert Stivers, R-Manchester, said he remains open to discussing the issue but personally has concerns about advancing legislation.
Stivers said has seen studies about the therapeutic benefits of medicinal marijuana, but said the ones he’s seen have had small sample sizes or were conducted over a short period of time.
“This is not a drug that’s a panacea to cure everything, but if there were more studies and the FDA or John Hopkins or somebody like that would come out and show how it should be used for medicinal and therapeutic values, then I think it would be an easier path forward,” Stivers said.
He also is worried about how legalizing marijuana for medicinal use could impact Kentucky’s crime rate.
Senate Democratic Leader Morgan McGarvey, D-Louisville, said he thinks the legalization of medical marijuana is long overdue.
“It is absolutely crazy that we don’t have medical marijuana in Kentucky,” McGarvey said. “It has overwhelming support by the people. It’s passed with bipartisan support in the House of Representatives and it was blocked by the Senate. That block in the Senate needs to go down. I think we can pass it this year, we should pass it this year and even the governor has been leaning on this which gives it a better chance.” [Read more at WHAS 11]
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
No comments so far.
Be first to leave comment below.